Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

But NICE drops psychiatric consultation stipulation
Company hopes to reinvigorate stagnating sales
Side-effect doubts overcome using data from 34,000 patients
BMS could receive up to $750 million from deal
Salesforce may need to be expanded to rapidly maximise sales
Eisai requests judicial review to investigate NICE's controversial decision
Pfizer and GSK lead the way with eco-friendly initiatives
Purchase is further addition to GSK's cancer drug programme
Phase III trials of SPP301 halted after fluid retention problem found in patients
But high cost could hamper its success in Europe
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches